FDA.reportPublic FDA data

2 ML pozelimab-bbfg 200 MG/ML Injection

RxCUI
2663945
RxNorm name
2 ML pozelimab-bbfg 200 MG/ML Injection
Display name
2 ML pozelimab-bbfg 200 MG/ML Injection
Full name
2 ML pozelimab-bbfg 200 MG/ML Injection
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:14

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761339Veopozpozelimab-bbfg351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
VEOPOZPOZELIMABRegeneron Pharmaceuticals, Inc.a8d6f10e-9430-450a-a3dd-b538f9b2a3082025-12-04Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2663945

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
a8d6f10e-9430-450a-a3dd-b538f9b2a3082 ML pozelimab-bbfg 200 MG/ML InjectionSCD6These highlights do not include all the information needed to use VEOPOZ safely and effectively. See full prescribing information for VEOPOZ. VEOPOZ ® (pozelimab-bbfg) injection, for intravenous or subcutaneous use Initial U.S. Approval: 202320251204
a8d6f10e-9430-450a-a3dd-b538f9b2a308pozelimab-bbfg 400 MG per 2 ML InjectionSY6These highlights do not include all the information needed to use VEOPOZ safely and effectively. See full prescribing information for VEOPOZ. VEOPOZ ® (pozelimab-bbfg) injection, for intravenous or subcutaneous use Initial U.S. Approval: 202320251204
a8d6f10e-9430-450a-a3dd-b538f9b2a308pozelimab-bbfg 400 MG in 2 ML InjectionPSN6These highlights do not include all the information needed to use VEOPOZ safely and effectively. See full prescribing information for VEOPOZ. VEOPOZ ® (pozelimab-bbfg) injection, for intravenous or subcutaneous use Initial U.S. Approval: 202320251204